We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$19.6B
AUM Growth
+$6.69B
Cap. Flow
+$6.14B
Cap. Flow %
31.32%
Top 10 Hldgs %
38.67%
Holding
659
New
42
Increased
95
Reduced
265
Closed
61

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$62M
2
WFC icon
Wells Fargo
WFC
+$37.5M
3
KMX icon
CarMax
KMX
+$33.1M
4
EMR icon
Emerson Electric
EMR
+$32.3M
5
EVR icon
Evercore
EVR
+$27.3M

Sector Composition

Rank Sector Weight
1 Financials 8.45%
2 Technology 7.68%
3 Healthcare 6.17%
4 Consumer Discretionary 5%
5 Communication Services 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
126
Medtronic
MDT
$107B
$27.2M 0.14%
336,897
-44,721
-12% -$3.58M
NOC icon
127
Northrop Grumman
NOC
$77B
$27.1M 0.14%
88,430
-5,650
-6% -$1.7M
RDN icon
128
Radian Group
RDN
$5.14B
$25.5M 0.13%
1,235,234
-799,248
-39% -$16.5M
WPXP
129
DELISTED
WPX Energy, Inc.
WPXP
$25.2M 0.13%
407,607
+9,411
+2% +$515K
ZION icon
130
Zions Bancorporation
ZION
$10.1B
$24M 0.12%
471,308
+59,697
+15% +$2.86M
UPS icon
131
United Parcel Service
UPS
$97.6B
$23.7M 0.12%
198,695
-108,621
-35% -$12.8M
CPAY icon
132
Corpay
CPAY
$24.2B
$23.3M 0.12%
121,068
-50,079
-29% -$8.81M
VGK icon
133
Vanguard FTSE Europe ETF
VGK
$30B
$23.1M 0.12%
390,500
GILD icon
134
Gilead Sciences
GILD
$161B
$22.6M 0.12%
315,847
-2,987
-0.9% -$227K
LHX icon
135
L3Harris
LHX
$55.9B
$22.5M 0.11%
158,705
+5,209
+3% +$727K
DYNC
136
DELISTED
Vistra Energy Corp.
DYNC
$21.8M 0.11%
275,000
AIG icon
137
American International
AIG
$41.9B
$21.7M 0.11%
363,488
-13,154
-3% -$808K
NKE icon
138
Nike
NKE
$61.9B
$21.5M 0.11%
344,247
-162,701
-32% -$9.35M
DHI icon
139
D.R. Horton
DHI
$41B
$21.5M 0.11%
420,847
-321,062
-43% -$15M
COP icon
140
ConocoPhillips
COP
$147B
$21.4M 0.11%
390,474
+213,798
+121% +$11M
WBA
141
DELISTED
Walgreens Boots Alliance
WBA
$21.4M 0.11%
294,890
-18,836
-6% -$1.33M
COF icon
142
Capital One
COF
$124B
$21.2M 0.11%
212,807
+138,063
+185% +$12.6M
FIS icon
143
Fidelity National Information Services
FIS
$21.5B
$20.9M 0.11%
222,381
-1,659
-0.7% -$156K
TFC icon
144
Truist Financial
TFC
$63.2B
$20.8M 0.11%
418,239
-11,778
-3% -$569K
IBB icon
145
iShares Biotechnology ETF
IBB
$9.31B
$20.4M 0.1%
191,205
TSS
146
DELISTED
Total System Services, Inc.
TSS
$20.3M 0.1%
256,383
-1,731
-0.7% -$126K
TRU icon
147
TransUnion
TRU
$14.8B
$20.2M 0.1%
368,316
-100,158
-21% -$5.33M
CVSA
148
Covista Inc
CVSA
$3.94B
$20.2M 0.1%
480,604
-3,054
-0.6% -$120K
BP icon
149
BP
BP
$113B
$20M 0.1%
518,910
-7,803
-1% -$283K
AET
150
DELISTED
Aetna Inc
AET
$19.7M 0.1%
109,358
-267,390
-71% -$45.9M

Similar funds

Calamos Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Calamos Advisors held 659 positions worth $19.6B, up 52% from $12.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Calamos Advisors deployed $6.14B of net new capital in Q4 2017, opening 42 new positions and adding to 95 existing holdings. Its largest new stake was Evercore: 327,688 shares worth $29.5M.

By sector, the portfolio is most concentrated in Financials at 8.5% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Citigroup, an estimated $92.2M trimmed.

  • Calamos Advisors's largest Q4 2017 buy was Evercore: 327,688 shares worth $29.5M.
  • Calamos Advisors added most to AbbVie in Q4 2017, an estimated $62M increase.
  • Calamos Advisors's biggest Q4 2017 reduction was Citigroup, cutting an estimated $92.2M.
  • Calamos Advisors fully exited T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2017, selling an estimated $51.1M.
  • Calamos Advisors's ten largest holdings make up 39% of its $19.6B portfolio in Q4 2017.
  • Calamos Advisors opened 42 new positions and closed 61 in Q4 2017.
  • Calamos Advisors's portfolio value rose 52% quarter-over-quarter to $19.6B.

Based on Calamos Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.